Bone morphogenetic protein excipients: Comparative observations on poloxamer

Plastic and Reconstructive Surgery

Volumn 105, Issue 2, 2000, Pages 628-637

  Clokie, Cameron M L ^b   Urist, Marshall R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN; POLOXAMER;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOCOMPATIBILITY; BONE GRAFT; BONE MATRIX; BONE REMODELING; CONTROLLED STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION;

EID: 0033969644     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006534-200002000-00023     Document Type: Article

References (58)

1. Dorland's Illustrated Medical Dictionary, 26th Ed. Toronto: Saunders, 1981.
2. Gregor, H. P., Hsia, H. T., Palevsky, S., Neuwirth, R. S., and Richard, R. M. Controlled Release Polymeric Formulations. Washington, D.C.: American Chemical Society, 1976. P. 147.
3. Urist, M. R. Bone: Formation by autoinduction. Science 150: 893, 1965.
4. Urist, M. R., Silverman, B. F., Büring, K., Dubuc, F. L., and Rosenberg, J. M. The bone induction principle. Clin. Orthop. Relat. Res. 53: 243, 1967.
5. Urist, M. R., DeLange, R. J., and Finerman, G. A. Bone cell differentiation and growth factors. Science 220: 680, 1983.
6. Urist, M. R., Granstein, R., Nogami, H., Svenson, L., and Murphy, R. Transmembrane bone morphogenesis across multiple-walled diffusion chambers: New evidence for a diffusible bone morphogenetic property. Arch. Surg. 112: 612, 1977.
7. Urist, M. R. Bone Morphogenetic Proteins: Biology, Biochemistry and Reconstructive Surgery. Georgetown, Texas: R.G. Landes Company, 1996. P. 7.
8. Wozney, J. M., Rosen, V., Byrne, M., Celeste, A. J., Moutsatsos, I., and Wang, E. A. Growth factors influencing bone development. J. Cell Sci. Suppl. 13: 149, 1990.
9. Urist, M. R., Huo, Y. K., Brownell, A. G., et al. Purification of bovine bone morphogenetic protein by hydroxyapatite chromatography. Proc. Natl. Acad. Sci. U.S.A. 81: 371, 1984.
10. Urist, M. R., Mikulski, A., and Conteas, C. N. Reversible extinction of the morphogen in bone matrix by reduction and oxidation of disulfide bonds. Calcif. Tissue Res. 19: 73, 1975.
11. Urist, M. R. Handbook of Biomaterials and Applications. Boston: Marcel Dekker, 1995. P. 1093.
12. Rosen, V., Wozney, J. M., Wang, E. A., et al. Purification and molecular cloning of a novel group of BMPs and localization of BMP mRNA in developing bone. Connect. Tissue Res. 20: 313, 1989.
13. Wang, E. A., Rosen, V., Cordes, P., et al. Purification and characterization of other distinct bone-inducing factors. Proc. Natl. Acad. Sci. U.S.A. 85: 9484, 1988.
14. Wozney, J. M. The bone morphogenetic protein family and osteogenesis. Mol. Reprod. Dev. 32: 160, 1992.
15. Wozney, J. M., Rosen, V., Celeste, A. J., et al. Novel regulators of bone formation: Molecular clones and activities. Science 242: 1528, 1988.
16. Celeste, A. J., Iannazzi, J. A., Taylor, R. C., et al. Identification of transforming growth factor beta family members present in bone-inductive protein purified from bovine bone. Proc. Natl. Acad. Sci. U.S.A. 87: 9843, 1990.
17. Luyten, F. P., Cunningham, N. S., Ma, S., et al. Purification and partial amino acid sequence of osteogenin, a protein initiating bone differentiation. J. Biol. Chem. 264: 13377, 1989.
18. Mellonig, J. T., Bowers, G. M., Bright, R. W., and Lawrence, J. J. Clinical evaluation of freeze-dried bone allografts in periodontal osseous defects. J. Periodontol. 47: 125, 1976.
19. Sepe, W. W., Bowers, G. M., Lawrence, J. J., Friedländer, G. E., and Koch, R. W. Clinical evaluation of freeze-dried bone allografts in periodontal osseous defects: Part II. J. Periodontol. 49: 9, 1978.
20. Quintero, G., Mellonig, I. T., Gambill, V. M., and Pelleu, G. B., Jr. A six-month clinical evaluation of decalcified freeze-dried bone allografts in periodontal osseous defects. J. Periodontol. 53: 726, 1982.
21. Becker, W., Urist, M. R., Tucker, L. M., Becker, B. E., and Ochsenbein, C. Human demineralized freeze-dried bone: Inadequate induced bone formation in athymic mice. A preliminary report. J. Periodontol. 66: 822, 1995.
22. Becker, W., Urist, M., Becker, B. E., et al. Clinical and histologic observations of sites implanted with intraoral autologous bone grafts or allografts: 15 human case reports. J. Periodontol. 67: 1025, 1996.
23. Garraway, R., Young, W. G., Daley, T., Harbrow, D., and Bartold, P. M. An assessment of the osteoinductive potential of commercial demineralized freeze-dried bone in the murine thigh muscle implantation model. J. Periodontol. 69: 1325, 1998.
24. Becker, W., Clokie, C., Sennerby, L., Urist, M. R., and Becker, B. E. Histologic findings after implantation and evaluation of different grafting materials and titanium micro screws into extraction sockets: Case reports. J. Periodontol 69: 414, 1998.
25. Zhang, M., Powers, R. M., Jr., and Wolfinbarger, L., Jr. Effect(s) of the demineralization process on the osteoinductivity of demineralized bone matrix. J. Periodontol. 68: 1085, 1997.
26. Zhang, M., Powers, R. M., Jr., and Wolfinbarger, L., Jr. A quantitative assessment of osteoinductivity of human demineralized bone matrix. J. Periodontol. 68: 1076, 1997.
27. Shigeyama, Y., D'Errico, J. A., Stone, R., and Somerman, M. J. Commercially-prepared allograft material has biological activity in vitro. J. Periodontol. 66: 478, 1995.
28. Kawai, T., and Urist, M. R. Quantitative comptitation of induced heterotopic bone formation by an image analysis system. Clin. Orthop. Relat. Res. 233: 262, 1988.
29. Kawamura, M., Iwata, H., Sato, K., and Miura, T. Chondroosteogenetic response to crude bone matrix proteins bound to hydroxyapatite. Clin. Orthop. 217: 281, 1987.
30. Takaoka, K., Koezuka, M., and Nakahara, H. Telopeptide-depleted bovine skin collagen as a carrier for bone morphogenetic protein. J. Orthop. Res. 9: 902, 1991.
31. Ripamonti, U., Duneas, N., Van Den Heever, B., Bosch, C., and Crooks, J. Recombinant transforming growth factor-betal induces endochondral bone in the baboon and synergizes with recombinant osteogenic protein-1 (bone morphogenetic protein-7) to initiate rapid bone formation. J. Bone Miner. Res. 12: 1584, 1997.
32. Bessho, K., Tagawa, T., and Murata, M. Purification of rabbit bone morphogenetic protein derived from bone, dentin, and wound tissue after tooth extraction. J. Oral Maxillofac. Surg. 48: 162, 1990.
33. Nogami, H., Ono, Y., and Oohira, A. Bioassay of chondrocyte differentiation by bone morphogenetic protein. Clin. Orthop. 258: 295, 1990.
34. Kuboki, Y., Takita, H., Kobayashi, D., et al. BMP-induced osteogenesis on the surface of hydroxyapatite with geometrically feasible and nonfeasible structures: Topology of osteogenesis. J. Biomed. Mater. Res. 39: 190, 1998.
35. Asahi Denka Kogyo Co. Pluronic and Tetronic Gels. Publication no. 4., 1981.
36. Schmolka, I. R. Preparation and properties of Pluronic F-127 for treatment of burns. J. Biomed. Mater. Res. 6: 571, 1972.
37. Nash, V. J., Johnston, T. P., and Palmer, W. K. Effects of nicotinic acid on poloxamer 407-induced hyperlipidemia. Pharmacotherapy 16: 10, 1996.
38. Hom, D. B., Medhi, K., Assefa, G., Juhn, S. K., and Johnston, T. P. Vascular effects of sustained-release fibroblast growth factors. Ann. Otol. Rhinol. Laryngol. 105: 109, 1996.
39. Suh, H., Jun, H W., Dzimianski, M. T., and Lu, G. W. Pharmacokinetic and local tissue disposition studies of naproxen-following topical and systemic administration in dogs and rats. Biopharm. DrugDispos. 18: 623, 1997.
40. Stratton, L. P., Dong, A., Manning, M. C., and Carpenter, J. F. Drug delivery matrix containing native protein precipitates suspended in a poloxamer gel. J. Pharm. Sci. 86: 1006, 1997.
41. Johnston, T. P., and Palmer, W. K. Effect of poloxamer 407 on the activity of microsomal 3-hydroxy-3-methylglutaryl CoA reductase in rats. J. Cardiovasc. Pharmacol. 29: 580, 1997.
42. Edsman, K., Carlfors, J., and Petersson, R. Rheological evaluation of poloxamer as an in situ gel for ophthalmic use. Eur. J. Pharm. Sci. 6: 105, 1998.
43. Bochot, A., Fattal, E., Gulik, A., Couarraze, G., and Couvreur, P. Liposomes dispersed within a thermosensitive gel: A new dosage form for ocular delivery of oligonucleotides. Pharm. Res. 15: 1364, 1998.
44. Katakam, M., and Banga, A. K. Use of poloxamer polymers to stabilize recombinant human growth hormone against various processing stresses. Pharm. Dev. Technol. 2: 143, 1997.
45. Mohammed, S., Pack, A. R., and Kardos, T. B. The effect of transforming growth factor beta one (TGF-beta 1) on wound healing, with or without barrier membranes, in a class II furcation defect in sheep. J. Periodontol. Res. 33: 335, 1998.
46. Mizutani, H., and Urist, M. R. The nature of bone morphogenetic protein (BMP) fractions derived from bovine bone matrix gelatin. Clin. Orthop. 171: 213, 1982.
47. Bessho, K., Tagawa, T., and Murata, M. Purification of bone morphogenetic protein derived from bovine bone matrix. Biochem. Biophys. Res. Commun. 165: 595, 1989.
48. Ko, L., Ma, G. X., and Gao, H. L. Purification and chemical modification of porcine bone morphogenetic protein. Clin. Orthop. 256: 229, 1990.
49. Urist, M. R. Experimental Delivery Systems for Bone Morphogenetic Protein. In D. L. Wise, D. E. Altobelli, E. R. Schwartz, J. D. Gresser, D. J. Trantolo, and M. Yaszemski (Eds.), Handbook of Biomaterials and Applications. Section 3: Orthopaedic Biomaterials Applications. Boston: Marcel Dekker, 1995. Pp. 1093-1133.
50. Hollinger, J. O., and Leong, K. Poly(alpha-hydroxy acids): Carriers for bone morphogenetic proteins. Biomaterials 17: 187, 1996.
51. Cook, S. D., and Rueger, D. C. Osteogenic protein-1: Biology and applications. Clin. Orthop. 324: 29, 1996.
52. Zellin, G., and Linde, A. Importance of delivery systems for growth-stimulatory factors in combination with osteopromotive membranes: An experimental study using rhBMP-2 in rat mandibular defects. J. Biomed. Mater. Res. 35: 181, 1997.
53. Whang, K., Tsai, D. C., Nam, E. K., et al. Ectopic bone formation via rhBMP-2 delivery from porous bioabsorbable polymer scaffolds. J. Biomed. Mater. Res. 42: 491, 1998.
54. Rodgers, J. B., Vasconez, H. C., Wells, M. D., et al. Two lyophilized polymer matrix recombinant human bone morphogenetic protein-2 carriers in rabbit calvarial defects. J. Craniofac. Surg. 9: 147, 1998.
55. Kuboki, Y., Takita, H., Kobayashi, D., et al. BMP-induced osteogenesis on the surface of hydroxyapatite with geometrically feasible and nonfeasible structures: Topology of osteogenesis. J. Biomed. Mater. Res. 39: 190, 1998.
56. Oda, S., Kinoshita, A., Higuchi, T., Shizuya, T., and Ishikawa, I. Ectopic bone formation by biphasic calcium phosphate (BCP) combined with recombinant human bone morphogenetic protein-2 (rhBMP-2). J. Med. Dent. Sci. 44: 53, 1997.
57. Isobe, M., Yamazaki, Y., Oida, S., Ishihara, K., Nakabayashi, N., and Amagasa, T. Bone morphogenetic protein encapsulated with a biodegradable and biocompatible polymer. J. Biomed. Mater. Res. 32: 433, 1996.
58. Omura, S., Mizuki, N., Kawabe, R., Ota, S., Kobayashi, S., and Fujita, K. A carrier for clinical use of recombinant human BMP-2: Dehydrothermally cross-linked composite of fibrillar and denatured atelocollagen sponge. Int. J. Oral Maxillofac. Surg. 27: 129, 1998.